Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

The cervical examination on admission was 1 cm dilated, 50% effaced, medium consistency and posterior, −3 station, vertex presentation, equivalent to a Bishop score of 3, with membranes intact.

In the phase 1b combination study, a total of ten patients, nine of whom had progressed on prior anti-PD1/PD-L1 therapies were enrolled at doses of 3, 10, and 20 mg/kg. Patients remained on ...

After hours: February 7 at 7:31:24 PM EST Loading Chart for VERX ...

Treasury yields from 7 to 30 years out trade at or above 3%, a day after Fed delivers half-point rate hike ...

Body Dimensions 164.7 x 75 x 7.6 mm (6.48 x 2.95 x 0.30 in) ...